Cargando…

Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa

Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among...

Descripción completa

Detalles Bibliográficos
Autores principales: Takasaki, Kenji, Enatsu, Kaori, Kumagami, Hidetaka, Takahashi, Haruo
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809338/
https://www.ncbi.nlm.nih.gov/pubmed/20130774
http://dx.doi.org/10.1155/2009/495186
_version_ 1782176616972025856
author Takasaki, Kenji
Enatsu, Kaori
Kumagami, Hidetaka
Takahashi, Haruo
author_facet Takasaki, Kenji
Enatsu, Kaori
Kumagami, Hidetaka
Takahashi, Haruo
author_sort Takasaki, Kenji
collection PubMed
description Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among them, 10 participants had allergic rhinitis (AR) (Group I), and others did not have AR (Group II). Nasal mucosa and blood were collected 55 to 130 minutes after oral administration of BB 10 mg. Concentrations of the agent in the serum and nasal mucosa were measured by high-performance liquid chromatography. Results. Concentrations of BB of the serum in Group I and II were 98 ± 32 ng/mL and 112 ± 39 ng/mL. Those of the nasal mucosa tissue in Groups I and II were 101 ± 36 ng/g and 132 ± 44 ng/g. There was no significant difference in the values of concentration of BB between the serum and the nasal mucosa in either Group I or II (P = .757 and P = .2662, resp., Paired t-test). Conclusion. This preliminary study is considered the first report on the concentration of H1-receptor antagonists in nasal mucosa. The prompt absorption and transition to the nasal mucosa of BB seems to have an effect on allergic rhinitis.
format Text
id pubmed-2809338
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28093382010-02-03 Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa Takasaki, Kenji Enatsu, Kaori Kumagami, Hidetaka Takahashi, Haruo Int J Otolaryngol Clinical Study Aims. To measure blood and tissue concentrations of the H1-receptor antagonist, bepotastine besilate (BB). Methods. Participants included 14 men and six women, whose age ranged from 13 to 76 years, with chronic rhinosinusitis, who underwent endoscopic sinus surgery at our university hospital. Among them, 10 participants had allergic rhinitis (AR) (Group I), and others did not have AR (Group II). Nasal mucosa and blood were collected 55 to 130 minutes after oral administration of BB 10 mg. Concentrations of the agent in the serum and nasal mucosa were measured by high-performance liquid chromatography. Results. Concentrations of BB of the serum in Group I and II were 98 ± 32 ng/mL and 112 ± 39 ng/mL. Those of the nasal mucosa tissue in Groups I and II were 101 ± 36 ng/g and 132 ± 44 ng/g. There was no significant difference in the values of concentration of BB between the serum and the nasal mucosa in either Group I or II (P = .757 and P = .2662, resp., Paired t-test). Conclusion. This preliminary study is considered the first report on the concentration of H1-receptor antagonists in nasal mucosa. The prompt absorption and transition to the nasal mucosa of BB seems to have an effect on allergic rhinitis. Hindawi Publishing Corporation 2009 2009-11-25 /pmc/articles/PMC2809338/ /pubmed/20130774 http://dx.doi.org/10.1155/2009/495186 Text en Copyright © 2009 Kenji Takasaki et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Takasaki, Kenji
Enatsu, Kaori
Kumagami, Hidetaka
Takahashi, Haruo
Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title_full Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title_fullStr Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title_full_unstemmed Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title_short Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa
title_sort concentrations of h1-receptor antagonist in the human nasal mucosa
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809338/
https://www.ncbi.nlm.nih.gov/pubmed/20130774
http://dx.doi.org/10.1155/2009/495186
work_keys_str_mv AT takasakikenji concentrationsofh1receptorantagonistinthehumannasalmucosa
AT enatsukaori concentrationsofh1receptorantagonistinthehumannasalmucosa
AT kumagamihidetaka concentrationsofh1receptorantagonistinthehumannasalmucosa
AT takahashiharuo concentrationsofh1receptorantagonistinthehumannasalmucosa